Company news
Medicus Pharma Ltd. news in 2024
Medicus Pharma Ltd.'s news releases, calls and decks from 2024, newest first.
Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch
December 11, 2024
Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region
December 1, 2024
Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
November 17, 2024
Medicus Pharma Ltd. Announces Closing of US$4.0M Initial Public Offering in the United States
November 14, 2024